生物活性 | |||
---|---|---|---|
描述 | The enzyme family protein kinase C (PKC) occupies a central role in the transduction of signals from a variety of mediators across the cell membrane. Inhibition of PKC may provide therapy for diseases such as rheumatoid arthritis (through inhibition of T-cell proliferation), cancer and AIDS (through inhibition of viral entry and viral gene expression). Bisindolylmaleimide IV is a potent PKC inhibitor, with IC50s ranging from 0.1 to 0.55 μM. It also inhibits PKA (cAMP-dependent protein kinase) with IC50s ranging from 3.1 to 11.8 μM[1]. Moreover, Bisindolylmaleimide IV has a good anti-HCMV (human cytomegaloviru) activity with an IC50 value of 0.2 μM[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.31mL |
15.27mL 3.05mL 1.53mL |
30.55mL 6.11mL 3.05mL |
参考文献 |
---|